Advisers say FDA's opioid REMS program needs improvement.
about
Advisers say FDA's opioid REMS program needs improvement.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Advisers say FDA's opioid REMS program needs improvement.
@en
Advisers say FDA's opioid REMS program needs improvement.
@nl
type
label
Advisers say FDA's opioid REMS program needs improvement.
@en
Advisers say FDA's opioid REMS program needs improvement.
@nl
prefLabel
Advisers say FDA's opioid REMS program needs improvement.
@en
Advisers say FDA's opioid REMS program needs improvement.
@nl
P356
P1476
Advisers say FDA's opioid REMS program needs improvement.
@en
P304
P356
10.2146/NEWS160040
P50
P577
2016-07-01T00:00:00Z